Net profit of Gland Pharma rose 12.32% to Rs 183.68 crore in the quarter ended September 2025 as against Rs 163.53 crore during the previous quarter ended September 2024. Sales rose 5.77% to Rs 1486.88 crore in the quarter ended September 2025 as against Rs 1405.83 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended |
| Sep. 2025 | Sep. 2024 | % Var. |
| Sales | 1486.88 | 1405.83 | 6 |
| OPM % | 21.11 | 21.13 | - |
| PBDT | 390.23 | 350.60 | 11 |
| PBT | 283.92 | 256.78 | 11 |
| NP | 183.68 | 163.53 | 12 |